Related Experiment Video
Updated: Nov 5, 2025

08:40
Author Spotlight: A Novel 3D-Printed Titanium Implant for Minimally Invasive Treatment of Hip Dysplasia in Young Dogs
Published on: April 19, 2024
3.1K
Ban veterinary use of diclofenac in Europe
Antoni Margalida1, Rhys E Green2, Fernando Hiraldo3
1Instituto de Investigación en Recursos Cinegéticos, Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Castilla-La Mancha, E-13005 Ciudad Real, Spain. a.margalida@csic.es.
Abstract
No abstract available in PubMed .
Related Concept Videos
Drug Regulation
2.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.2K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
266
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
266
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
277
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
277

